Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants
S. Tan, X. Hu, Y. Li, Z. Wu, J. Zhao, G. Lu, Z. Yu, B. Du, Y. Liu, L. Li, Y. Chen, Y. Yao, X. Zhang, J. Rao, G. Gao, , J. Lin
This paper evaluates RQ3013, an mRNA vaccine against SARS-CoV-2 variants, showing robust immune responses and protection in animal models.
Science Bulletin · Dec 1, 2023Peer-reviewedImmunology